In next step of opi­oid saga, McK­in­sey reach­es pro­posed agree­ment with school dis­tricts and lo­cal gov­ern­ments

More than 18 months af­ter agree­ing to pay $600 mil­lion to set­tle opi­oid mar­ket­ing claims, McK­in­sey told a fed­er­al judge this week that it has reached an­oth­er set­tle­ment.

The con­sult­ing firm, which worked with opi­oid mak­ers such as Pur­due Phar­ma on how to mar­ket their prod­ucts, told a fed­er­al judge Wednes­day that it had reached a deal with a num­ber of school dis­tricts and lo­cal gov­ern­ments.

The fil­ing in Cal­i­for­nia’s North­ern Dis­trict Court reads:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER